Eastland gets nod for first trial of malaria treatment

Perth-based Eastland Medical Systems Ltd says it is on track with the development of its anti-malaria treatment ArTiMistTM and will commence a multi-dose Phase 1 clinical trial in February, after its pharmaceutical division received regulatory approvals in South Africa.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
293rdRefresh Group27%20%
542ndAdvanced Braking Technology-14%-20%
638thSuda Pharmaceuticals-30%-16%
750thAvita Medical-51%-13%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$0 Issued
$0 Issued
$0 Issued
Total value as at the date of the transaction
Source: Morningstar


90th↑Avita Medical$8.0m
91st↓Advanced Braking Technology$7.7m
92nd↓Suda Pharmaceuticals$7.3m
94th↓Refresh Group$6.2m
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Suda Pharmaceuticals

490thStephen J Carter$279k
495thJoseph Ohayon$277k
1118thMichael Stewart$79k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer